Categoria: english

Last year was the year of megarounds for cannabis startups…

Eurox Pharma is a vertically integrated company with roots in the German and European production of herbal medicines. From this tradition, Eurox also ensures the highest quality along the entire value chain for medicinal cannabis extracts and the active ingredient dronabinol.

Eurox Pharma manufactures cannabis-based medicines and products in a state-of-the-art facility in Germany. The company relies on cutting-edge research and complies with the highest pharmaceutical quality and safety standards in Germany and the EU for operations and products.

Sales of Δ9-THC represents a new revenue stream for Eurox, which follows the distribution agreement of Eurox’s full-spectrum extracts to pharmacies during the previous calendar quarter.

Experts in the field of medical cannabis, including Eurox Group’s very own Mike Kindrat present at the Royal Society of Medicine.

Neil Smith, 56, is the chairman of Germany-based firm Eurox Pharma and CEO of the Integro Medical Clinic.

When it comes to the local supply of medicinal cannabis, one is mainly used to the names that one knows from looking across the Atlantic. As a European company, Eurox Pharma relies on cannabis extracts made in Germany to conquer the European market.

During the appointment, which lasted just under two hours, the two Eurox managing directors David Reckeweg-Lecompte and Dr. Bernhard Babel explained the special role of science in patient care with medical cannabis and the quality requirements that must be met. Eurox Pharma has entered into a production partnership with Dr. Reckeweg & Co. GmbH, which…

THE first home-made medical cannabis products will debut on the German market within weeks. This comes as Eurox Group – the producer of the derivatives range – has secured €3m growth capital from leading UK cannabis investors Fast Forward Innovations.

Cannabis medicine offers particular potential to improve patient care in Germany. The member of the Bundestag of Bündnis 90/Die Grünen, Daniela Wagner, and the two managing directors of Eurox Pharma, David Reckeweg-Lecompte and Dr. Bernhard Babel, agreed on this.